Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-24,800
Closed -$21K 2054
2023
Q1
$21K Hold
24,800
﹤0.01% 1864
2022
Q4
$32K Hold
24,800
﹤0.01% 1849
2022
Q3
$44K Hold
24,800
﹤0.01% 1845
2022
Q2
$56K Hold
24,800
﹤0.01% 1839
2022
Q1
$81K Hold
24,800
﹤0.01% 1882
2021
Q4
$112K Sell
24,800
-18,000
-42% -$136K ﹤0.01% 1876
2021
Q3
$307K Hold
42,800
﹤0.01% 1658
2021
Q2
$343K Buy
+42,800
New +$361K ﹤0.01% 1676

Other funds holding OCGN

STRS Ohio's OCGN Position: Q2 2023 in Review

STRS Ohio sold out of Ocugen (OCGN) in Q2 2023, closing a stake of 24,800 shares — an estimated $21K sold.

STRS Ohio first reported a position in OCGN in Q2 2021 and held it in 8 quarters. The position peaked at $343K in Q2 2021. 96 funds tracked by Wall St. Rank hold OCGN as of Q2 2023.

  • STRS Ohio reported no remaining Ocugen position as of Q2 2023 after selling out during the quarter.
  • STRS Ohio sold 24,800 Ocugen shares in Q2 2023, an estimated $21K.
  • STRS Ohio first reported a position in Ocugen in Q2 2021 and held it in 8 quarters.
  • STRS Ohio's Ocugen position peaked at $343K in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Ocugen as of Q2 2023.

Based on STRS Ohio's 13F filing for Q2 2023, filed 31 Jul 2023.